The effect of temperature of intravenous administration on occurrence of phlebitis and dwell time of intravenous catheters.

Compare the effect of temperature equalization of intravenous administration with body temperature and intravenous administration with environment temperature on occurrence of phlebitis and dwell time of short peripheral intravenous catheter in patients admitted to internal ward of Emam Ali' hospital in Sarayan

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017011531959N1

Enrollment

106

Registered

2017-02-19

Start date

2017-01-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phlebitis. Phlebitis and thrombophlebitis of other sites

Interventions

Intervention 1: Intervention group: temperature equalization of intravenous administration with body temperature (37?) with infusion pump. Intervention 2: In control group: intravenous administration

Prevention

Treatment - Drugs

Intervention group: temperature equalization of intravenous administration with body temperature (37?) with infusion pump.

In control group: intravenous administration at a mean temperature of environment (24?) with infusion pump.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Having informed consent for research; Age 18-65 years; having full consciousness; not having underlying diseases such as leukemia; immune deficiency and dermatitis; healthy upper limb, do not receive Immunosuppressant’s drug and chemotherapy; having a minimum of 72 hours intravenous catheter; don’t receive drugs that stimulate the vein wall and solution Hyperosmolar; no history of intravenous drug addiction. Exclusion Criteria: Disrupting or failure to completing the study because of transition to other unit or death; unwillingness to continue the study; need to receive stimulating and Hyperosmolar solutions and drugs during the study; receive intravenous fluids and medications less than 72 hours; sensitivity to adhesives.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Phlebitis. Timepoint: 24, 48 and 72 hours after intervention. Method of measurement: Phlebitis Scale from the Infusion Nurses society.	—

Secondary

Measure	Time frame
Dwell time of intravenous catheter. Timepoint: Time between insertion and discontinue of catheter. Method of measurement: Per hour.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmin Pirooz

Gonabad University of Medical Sciences

Apirooz3ca@gmail.com+98 51 5722 5027

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026